Search

everythinglearnresearchcommunity

for

Search:↓

Calanthoside may help hair growth by boosting cell proliferation.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Compound 1 showed promising anticancer activity.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

A new method to make finasteride for hair loss treatment was developed.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A new method creates unique chemical structures that could improve drug discovery.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

The salts have diverse molecular packing with significant hydrogen interactions.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.